免疫抑制的造血干细胞移植受者侵袭性真菌性鼻窦炎的危险因素
Invasive fungal sinusitis risk factors among immunosuppressed hematopoietic stem cell transplant recipients.
作者信息
Munyemana Marie-Ange, Pande Anupam, Kallogjeri Dorina, Farrell Nyssa F, Schneider John S, Kendall Peggy L, Roland Lauren T
机构信息
Clinical Outcomes Research Office, Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri, USA.
Cooper Medical School of Rowan University, Camden, New Jersey, USA.
出版信息
Int Forum Allergy Rhinol. 2023 Nov;13(11):2113-2118. doi: 10.1002/alr.23200. Epub 2023 Jun 7.
Abstract
Invasive fungal sinusitis (IFS) rate and risk factors in transplant recipients were explored IFS rate is higher in allogeneic recipients with prior transplants and worse comorbidity scores The at-risk timeframes for IFS development were identified.
摘要
对移植受者侵袭性真菌性鼻窦炎（IFS）的发生率及危险因素进行了探究。既往有移植史且合并症评分较差的同种异体受者的IFS发生率更高。确定了IFS发生的高危时间段。
相似文献
1
Invasive fungal sinusitis risk factors among immunosuppressed hematopoietic stem cell transplant recipients.免疫抑制的造血干细胞移植受者侵袭性真菌性鼻窦炎的危险因素
Int Forum Allergy Rhinol. 2023 Nov;13(11):2113-2118. doi: 10.1002/alr.23200. Epub 2023 Jun 7.
2
Intermediate Invasive Fungal Sinusitis, a Distinct Entity From Acute Fulminant and Chronic Invasive Fungal Sinusitis.中介型侵袭性真菌性鼻窦炎，一种有别于急性暴发性和慢性侵袭性真菌性鼻窦炎的独特实体。
Ann Otol Rhinol Laryngol. 2022 Sep;131(9):1021-1026. doi: 10.1177/00034894211052854. Epub 2021 Oct 25.
3
Invasive Rhinosinusitis Caused by Lasiodiplodia theobromae in an Allogeneic Hematopoietic Cell Transplant Recipient Case Report and Review of Literature.拉氏拟青霉致异基因造血干细胞移植受者侵袭性鼻窦真菌病 1 例报告并文献复习
Mycopathologia. 2018 Oct;183(5):841-845. doi: 10.1007/s11046-018-0262-9. Epub 2018 Jun 22.
4
Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.异基因造血细胞移植受者侵袭性真菌感染的危险因素及结局
Mycopathologia. 2017 Jun;182(5-6):495-504. doi: 10.1007/s11046-017-0115-y. Epub 2017 Jan 25.
5
Optimization of diagnostic and procedural codes to identify patients with acute invasive fungal sinusitis.优化诊断和操作代码以识别急性侵袭性真菌性鼻窦炎患者。
Int Forum Allergy Rhinol. 2024 Mar;14(3):728-731. doi: 10.1002/alr.23253. Epub 2023 Aug 22.
6
Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.每周一次脂质体两性霉素B预防造血干细胞移植伴移植物抗宿主病患者侵袭性真菌感染的耐受性及疗效
J Oncol Pharm Pract. 2016 Apr;22(2):228-34. doi: 10.1177/1078155214560920. Epub 2014 Dec 3.
7
[Clinical features and risk factors for invasive fungal sinusitis after allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植后侵袭性真菌性鼻窦炎的临床特征及危险因素]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jan 14;45(1):22-27. doi: 10.3760/cma.j.cn121090-20231009-00175.
8
The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.巨细胞病毒感染和巨细胞病毒血清状态与异基因造血干细胞移植受者侵袭性真菌感染的关系：系统评价和荟萃分析。
Clin Microbiol Infect. 2022 Mar;28(3):332-344. doi: 10.1016/j.cmi.2021.10.008. Epub 2021 Nov 6.
9
Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.异基因造血干细胞移植受者呼吸道病毒感染后肺侵袭性真菌病的发病率、危险因素及转归
Transpl Infect Dis. 2019 Oct;21(5):e13158. doi: 10.1111/tid.13158. Epub 2019 Sep 3.
10
Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.接受异基因造血干细胞移植的成年患者中可能的和确诊的侵袭性真菌感染的发病率及危险因素
J Microbiol Immunol Infect. 2016 Aug;49(4):567-74. doi: 10.1016/j.jmii.2015.01.002. Epub 2015 Jan 30.
本文引用的文献
1
Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence-Based Review with Recommendations.急性侵袭性真菌性鼻-鼻窦炎的诊断、预后因素和治疗：多学科共识声明和循证综述及推荐意见。
Int Forum Allergy Rhinol. 2023 Sep;13(9):1615-1714. doi: 10.1002/alr.23132. Epub 2023 Feb 19.
2
Current Use and Trends in Hematopoietic Cell Transplantation in the United States.美国造血细胞移植的当前应用与趋势
Biol Blood Marrow Transplant. 2017 Sep;23(9):1417-1421. doi: 10.1016/j.bbmt.2017.05.035. Epub 2017 Jun 9.
3
Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.异基因移植后的免疫重建以及免疫恢复对感染风险的影响。
Virulence. 2016 Nov 16;7(8):901-916. doi: 10.1080/21505594.2016.1208866. Epub 2016 Jul 6.
4
Prevalence of hematopoietic cell transplant survivors in the United States.美国造血细胞移植幸存者的患病率。
Biol Blood Marrow Transplant. 2013 Oct;19(10):1498-501. doi: 10.1016/j.bbmt.2013.07.020. Epub 2013 Jul 30.
5
Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients.造血干细胞移植受者的胸腺生成不足可预测机会性感染。
Haematologica. 2011 Dec;96(12):1846-54. doi: 10.3324/haematol.2011.047696. Epub 2011 Aug 22.
6
Thymic T-cell development in allogeneic stem cell transplantation.同种异体干细胞移植中的胸腺 T 细胞发育。
Blood. 2011 Jun 23;117(25):6768-76. doi: 10.1182/blood-2011-02-334623. Epub 2011 Mar 22.
7
Immunity to fungal infections.真菌感染的免疫。
Nat Rev Immunol. 2011 Apr;11(4):275-88. doi: 10.1038/nri2939. Epub 2011 Mar 11.
8
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.造血细胞移植（HCT）特异性合并症指数：一种用于异基因造血细胞移植前风险评估的新工具。
Blood. 2005 Oct 15;106(8):2912-9. doi: 10.1182/blood-2005-05-2004. Epub 2005 Jun 30.
9
Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity.去除T细胞的骨髓移植后免疫反应性的恢复取决于胸腺活性。
Blood. 2000 Sep 15;96(6):2299-303.
Zotero 插件